Publications
Original Article
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals"
Tumor Microenvironment
2006
Authors:
Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR and Kazim AL
Journal:
Breast Cancer Research and Treatment
Volume:
96(3)
Page:
243
Original Article
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice
Cancer Vaccines
2006
Authors:
Knutson KL, Dang Y, Lu H, Lukas J, Almand B, Gad E, Azeke E, and Disis ML
Journal:
Journal of Immunology
Volume:
177(1)
Page:
84-91
Original Article
Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain
General Immune Research
2006
Authors:
Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, and Ostrand-Rosenberg S
Journal:
Cancer Research
Volume:
66(2)
Page:
1147-54
Original Article
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion
Cancer Vaccines
2006
Authors:
Zhang H, Knutson KL, Hellstrom KE, Disis ML, and Hellstrom I
Journal:
Molecular Cancer Therapeutics
Volume:
5(1)
Page:
149-55
Original Article
Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers
General Immune Research
2006
Authors:
Benz CC, Fedele V, Xu F, Ylstra B, Ginzinger D, Yu M, Moore D, Kneuper-Hall D, Wolff DJ, Disis ML Eppenberger-Castori S, Eppenberger U, Schitulli F, Tommasi S, Paradiso A, Scott GK and Albertson D
Journal:
Genes Chromosomes Cancer
Volume:
45(11)
Page:
983-94
Original Article
Immunoediting of cancers may lead to epithelial to mesenchymal transition
Cancer Vaccines
2006
Authors:
Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, and Disis ML
Journal:
Journal of Immunology
Volume:
177(3)
Page:
1526-33
Original Article
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer
Cancer Diagnostics
2006
Authors:
Goodell V, Salazar LG, Urban N, Drescher C, Gray H, Swensen R, McIntosh MW, and Disis ML
Journal:
Journal of Clinical Oncology
Volume:
24(5)
Page:
762-8
Methods
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
Measuring Human Immunity
2006
Authors:
Disis ML, delaRosa C, Goodell V, Kuan LY, Chang JCC, Kuus-Reichel K, Clay T, Lyerly HK, Waters CA, Ghanekar SA, Maino VC and Maecker HT
Journal:
Journal of Immunology Methods
Volume:
308(1-2)
Page:
13-8
Review Article
Global role of the immune system in identifying cancer initiation and limiting disease progression
General Immune Research
2005
Authors:
Disis ML, Lyerly HK
Journal:
Journal of Clinical Oncology
Volume:
23(35)
Page:
8923-5
Review Article
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
T Cell Function & Therapy
2005
Authors:
Knutson KL and Disis ML
Journal:
Cancer Immunology Immunotherapy
Volume:
54(8)
Page:
721-8